Filing Details
- Accession Number:
- 0001209191-21-023869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-31 19:12:14
- Reporting Period:
- 2021-03-30
- Accepted Time:
- 2021-03-31 19:12:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710072 | Edgewise Therapeutics Inc. | EWTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1225480 | D Jonathan Root | C/O Edgewise Therapeutics, Inc. 3145 Colorado Ave. Boulder CO 80303 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-30 | 3,473,543 | $0.00 | 3,473,543 | No | 4 | C | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2021-03-30 | 15,625 | $16.00 | 15,625 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See Footnotes |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B-1 Preferred Stock | Disposition | 2021-03-30 | 1,651,607 | $0.00 | 1,651,607 | $0.00 |
| Common Stock | Series B-2 Preferred Stock | Disposition | 2021-03-30 | 1,366,707 | $0.00 | 1,366,707 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2021-03-30 | 455,229 | $0.00 | 455,229 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series B-2 Preferred Stock and Series C Preferred Stock converted into one share of the Issuer's Common Stock immediately prior to the completion of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- These securities are held of record by U.S. Venture Partners XI, L.P. ("USVP XI"). Presidio Management Group XI, L.L.C. ("PMG XI"), the general partner of USVP XI, has sole voting and dispositive power with respect to the shares held by USVP XI. The Reporting Person is a managing member of PMG XI with additional rights with respect to the issuer's securities, and may be deemed to have sole voting and dispositive power with respect to such shares. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
Billionaire Hedge Funds
